Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ANNX · NASDAQ · Pharmaceutical Preparations
$3.10−0.31 (−9.09%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Annexon (ANNX) · oqro.io/stocks/ANNX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 19, 2026 · Filed Nov 20, 2026
Director purchased ~$122K of ANNX shares in the open marketSource5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
BVF PARTNERS L P/IL cut its ANNX stake below 5% (4.4%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bellevue Group AG disclosed a reduced position in ANNX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Siren, L.L.C. disclosed an increased position in ANNX for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Longaeva Partners L.P. disclosed a reduced position in ANNX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed a new position in ANNX for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Longaeva Partners L.P. disclosed a new position in ANNX for Q4 2025SourceInsider trade · Traded Sep 2, 2025 · Filed Sep 4, 2025
Director purchased ~$8.6K of ANNX shares in the open marketSourceInsider trade · Traded Jul 30, 2025 · Filed Aug 1, 2025
Director purchased ~$10K of ANNX shares in the open marketSourceInsider trade · Traded Jul 14, 2025 · Filed Jul 16, 2025
CFO sold ~$2.9K of ANNX shares in the open marketSourceInsider trade · Traded Jul 14, 2025 · Filed Jul 16, 2025
Officer sold ~$2.2K of ANNX shares in the open marketSourceInsider trade · Traded Jul 14, 2025 · Filed Jul 16, 2025
Officer sold ~$2.9K of ANNX shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
Director purchased ~$10K of ANNX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 20, 2025
CFO sold ~$20K of ANNX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 20, 2025
Officer sold ~$24K of ANNX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 20, 2025
Officer sold ~$20K of ANNX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 20, 2025
Officer sold ~$16K of ANNX shares in the open marketSourceInsider trade · Traded Dec 2, 2024 · Filed Dec 4, 2024
Director purchased ~$17K of ANNX shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 17, 2024
Officer sold ~$40K of ANNX shares in the open marketSourceInsider trade · Traded Oct 1, 2024 · Filed Oct 2, 2024
Director purchased ~$19K of ANNX shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 20, 2025
Officer sold ~$16K of ANNX shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 18, 2025
CEO sold ~$15K of ANNX shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 18, 2025
CFO sold ~$5.3K of ANNX shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 18, 2025
Officer sold ~$5.3K of ANNX shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 18, 2025
Officer sold ~$4.3K of ANNX shares in the open marketSource